Last updated on July 2019

DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]


Brief description of study

This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane.

Clinical Study Identifier: NCT03529110

Find a site near you

Start Over

Washington Cancer Institute

Washington, WA United States
  Connect »

Cancer Research Collaboration

Santa Ana, CA United States
  Connect »

UCLA Hematology Oncology

Los Angeles, CA United States
  Connect »

Pacific Cancer Care

Monterey, CA United States
  Connect »

Norton Cancer Institute

Louisville, KY United States
  Connect »

Mercy Medical Center

Baltimore, MD United States
  Connect »

Research Medical Center

Kansas City, MO United States
  Connect »

Seidman Cancer Center

Cleveland, OH United States
  Connect »

Dayton Physicians, LLC

Kettering, OH United States
  Connect »

Allegheny General Hospital

Pittsburgh, PA United States
  Connect »

Magee-Womens Hospital of UPMC

Pittsburgh, PA United States
  Connect »

Sarah Cannon Research Institute

Chattanooga, TN United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Millennium Oncology

Houston, TX United States
  Connect »

Northern Utah Associates

Ogden, UT United States
  Connect »

ICM Val d'Aurelle

Montpellier, France
  Connect »

Centre Hospitalier Lyon Sud

Pierre Benite Cedex, France
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Institut Gustave Roussy

Villejuif cedex, France
  Connect »

Aberdeen Royal Infirmary

Aberdeen, United Kingdom
  Connect »

Guy's Hospital

London, United Kingdom
  Connect »

Western General Hospital

Edinburgh, United Kingdom
  Connect »

Sharp Memorial Hospital

San Diego, CA United States
  Connect »

Centre Paul Strauss

Strasbourg Cedex, France
  Connect »

H pital Nord - CHU Marseille

Marseille Cedex 20, France
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Hospital Universitario de Canarias

San Cristobal de la Laguna, Spain
  Connect »